Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Appareil génital féminin - autres
- | Specialty :
- Chimiothérapie
Extract
A phase III, open label, randomized, 2 arm study of ixabepilone administered every 21 days versus paclitaxel or doxorubicin administered every 21 days in women with advanced endometrial cancer who have previously been treated with chemotherapy.
Scientific Abstract
en cours d'intégration;